Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

NVAX
Novavax, Inc.
stock NASDAQ

At Close
9/28/2023 3:59:47 PM EDT
7.18USD-0.209%(-0.02)3,464,499
7.16Bid   8.55Ask   1.39Spread IEX
Pre-market
9/28/2023 9:28:30 AM EDT
7.20USD+0.139%(+0.01)0
After-hours
9/28/2023 4:00:30 PM EDT
7.16USD-0.209%(-0.02)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
677.350M
CEO
Stanley Erck
Headquarters
Gaithersburg, Maryland, USA
Industry
Biotechnology
Next Earnings
2023-11-08 (41d)
Last Split
2019-05-101for20reverse
Related
BCRXACHNCLDXAZNGSKNVSPFEEBSAGENSRPTXLV
NVAX Stats
Avg. Vol. 10 Day
9,853,615
Avg. Vol. 30 Day
12,498,972
Employees
1,992
Market Cap
677,350,027
Shares Out.
94,404,185
Float
81,401,230
P/E Ratio
-1.15
EPS (ttm)
-6.820
On/Off Exchange
48%/52%
6 Month Beta
1.42
1 Year Beta
1.98
2 Year Beta
1.34
3 Year Beta
1.32
52 Week Low
5.61
52 Week High
25.66
SMA50
7.90
SMA200
7.74
1 Week
+5.67%
1 Month
-14.12%
3 Month
-4.84%
6 Month
+16.48%
1 Year
-63.41%
2 Year
-96.50%
5 Year
-80.92%
Profile
novavax, inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. our recombinant nanoparticles and matrix-m™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. product pipeline our product pipeline targets a variety of infectious diseases with vaccine candidates currently in clinical development for respiratory syncytial virus ("rsv"​), seasonal influenza, pandemic influenza, and ebola virus ("ebov"​). we have additional preclinical-stage programs for a variety of infectious diseases. corporate overview novavax is headquartered in gaithersburg, maryland with additional facilities in rockville, maryland and uppsala, sweden. novavax is traded on the nasdaq stock market under the symbol nvax and employs over 300 individuals dedicated to developing novel vaccines to address infectious disease.

NVAX Stock Summary

Novavax, Inc. (NASDAQ:NVAX) stock price today is $7.18, and today's volume is 3,464,499. NVAX is down -0.209% today. The 30 day average volume is 12,498,972. NVAX market cap is 677.350M with 94,404,185 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC